文献速递胃肠外科围术期管理与 ERAS

生物合成补片加强修补食管裂孔疝:一项定性系统评价

Hiatal hernia repair with biosynthetic mesh reinforcement: a qualitative systematic review.
PubMed 文献 · Surg Endosc · 2023-09-18

本定性系统评价遵循PRISMA指南,使用RoBINS-I和RoB工具评估偏倚风险,最终纳入18篇文章(1846例患者),涉及BIO-A、Phasix ST和聚乳糖补片三种生物合成补片。结果显示补片安全有效,并发症率低、症状缓解率高,但复发率报道异质性大(0.9%-25%),需进一步开展大样本长期随访的随机对照试验。

要点

  • 生物合成补片加强修补食管裂孔疝安全有效,并发症率低、症状缓解率高。
  • 纳入18篇文章共1846例患者,涉及BIO-A、Phasix ST和聚乳糖补片三种材料。
  • 复发率报道异质性大(0.9%-25%),主要源于复发定义和评估标准不一。

核心结论

  • 使用生物合成补片进行食管裂孔疝修补是安全有效的,并发症率低且症状缓解率高。
  • 由于复发定义和评估存在显著异质性,报道的复发率高度可变。
  • 应开展更大样本和长期随访的随机对照试验以更好地分析结局和复发率。

研究设计与样本

  • 本系统评价遵循PRISMA指南,使用RoBINS-I和RoB工具对所有纳入研究进行定性评估。
  • 系统文献检索共找到520篇文章,其中101篇为重复文献,355篇被判定与本研究无关而排除,对剩余64篇文章的全文进行了全面评估。
  • 最终纳入18篇文章(共1846例患者),描述了使用BIO-A、Phasix ST和聚乳糖补片三种不同生物合成补片的食管裂孔疝修补。

主要发现

  • 平均手术时间范围为127至223分钟。
  • 平均随访时间范围为12至54个月。
  • 未发生补片侵蚀或补片取出。
  • 使用BIO-A补片报道了1例需再次手术的补片相关狭窄并发症。
  • 研究报告症状评分、生活质量评分及手术满意度均有显著改善;总体复发率范围为0.9%至25%。

关键数值与推荐

  • 复发被报道为影像学复发或临床复发。
  • 使用BIO-A补片报道了1例需再次手术的补片相关狭窄并发症。

临床怎么用

  • 原文结论未据此给出具体临床推荐。

局限性

  • 复发率报道高度可变,原因是复发定义和评估存在显著异质性。
  • 需要开展更大样本和长期随访的随机对照试验以更好地分析结局和复发率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Reinforcement of crural closure with synthetic resorbable mesh has been proposed to decrease recurrence rates after hiatal hernia repair, but continues to be controversial. This systematic review aims to evaluate the safety, efficacy, and intermediate-term results of using biosynthetic mesh to augment the hiatus. METHODS: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed throughout this systematic review. The Risk of Bias in Non-Randomized Studies of Interventions and Risk of Bias in Randomized Trials tools were used to perform qualitative assessment of all studies included in this review. Recommendations were then summarized for the following pre-defined key items: protocol, research question, search strategy, study eligibility, data extraction, study design, risk of bias, publication bias, and statistical analysis. RESULTS: The systematic literature search found 520 articles, 101 of which were duplicates and 355 articles were determined to be unrelated to our study and excluded. The full text of the remaining 64 articles was thoroughly assessed. A total of 18 articles (1846 patients) were ultimately included for this review, describing hiatal hernia repair using three different biosynthetic meshes-BIO-A, Phasix ST, and polyglactin mesh. Mean operative time varied from 127 to 223 min. Mean follow up varied from 12 to 54 months. There were no mesh erosions or explants. One mesh-related complication of stenosis requiring reoperation was reported with BIO-A. Studies showed significant improvement in symptom and quality-of-life scores, as well as satisfaction with surgery. Recurrence was reported as radiologic or clinical recurrence. Overall, recurrence rate varied from 0.9 to 25%. CONCLUSION: The use of biosynthetic mesh is safe and effective for hiatal hernia repair with low complications rates and high symptom resolution. The reported recurrence rates are highly variable due to significant heterogeneity in defining and evaluating recurrences. Further randomized controlled trials with larger samples and long-term follow-up should be performed to better analyze outcomes and recurrence rates.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Lima DL, de Figueiredo SMP, Pereira X, et al. Hiatal hernia repair with biosynthetic mesh reinforcement: a qualitative systematic review. Surg Endosc. 2023. PMID: 37721592. doi:10.1007/s00464-023-10379-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。